These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18605186)

  • 21. Treatment of children persistently infected with hepatitis B virus: seroconversion or suppression.
    Price N; Boxall EH
    J Antimicrob Chemother; 2007 Dec; 60(6):1189-92. PubMed ID: 17913721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of chronic hepatitis B.
    Yuen MF; Lai CL
    Lancet Infect Dis; 2001 Nov; 1(4):232-41. PubMed ID: 11871510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hepatitis B after renal transplantation: an update.
    Fabrizi F; Lunghi G; Poordad FF; Martin P
    J Nephrol; 2002; 15(2):113-22. PubMed ID: 12018626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
    Fung S; Kwan P; Fabri M; Horban A; Pelemis M; Hann HW; Gurel S; Caruntu FA; Flaherty JF; Massetto B; Dinh P; Corsa A; Subramanian GM; McHutchison JG; Husa P; Gane E
    Gastroenterology; 2014 Apr; 146(4):980-8. PubMed ID: 24368224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral therapy in patients with chronic hepatitis B and cirrhosis.
    Lai CJ; Terrault NA
    Gastroenterol Clin North Am; 2004 Sep; 33(3):629-54, x-xi. PubMed ID: 15324948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of HBV gene variations on disease development and antiviral therapy for patients with chronic hepatitis B.
    Chen JY; Wang LW; Sun XM; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):393-7. PubMed ID: 16109523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral therapy for treatment-naïve hepatitis B virus patients.
    Lau DT; Membreno FE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):581-99, ix-x. PubMed ID: 15324945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.
    Ristig MB; Crippin J; Aberg JA; Powderly WG; Lisker-Melman M; Kessels L; Tebas P
    J Infect Dis; 2002 Dec; 186(12):1844-7. PubMed ID: 12447773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus genotypes and response to antiviral therapy.
    Enomoto M; Tamori A; Nishiguchi S
    Clin Lab; 2006; 52(1-2):43-7. PubMed ID: 16506363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The HBeAg/antiHBe seroconversion as a result of lamivudine treatment in children with chronic hepatitis B unresponsive to previous interferon alpha therapy].
    Lebensztejn DM; Skiba E; Sobaniec-Lotowska M; Kaczmarski M
    Pol Merkur Lekarski; 2004 Jun; 16(96):557-9. PubMed ID: 15510896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B].
    Zhou HJ; Li SG; Wen FY; Yang XY; Wu JL; Tan B; Fu J
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):564-8. PubMed ID: 19719911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of lamivudine and interferon-alpha combination therapy on chronic hepatitis B].
    Tang Y; Chen G; Zheng R
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):89. PubMed ID: 11983118
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of chronic hepatitis B virus infection: a new era of disease control.
    Farrell GC; Teoh NC
    Intern Med J; 2006 Feb; 36(2):100-13. PubMed ID: 16472264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better.
    Choe BH; Lee JH; Jang YC; Jang CH; Oh KW; Kwon S; Hyun MC; Ko CW; Lee KS; Lee WK
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):92-8. PubMed ID: 17204960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Retrospective cohort study of lamivudine therapy in patients with chronic hepatitis B].
    Teuber G; Löhr HF; Kallinowski B; Berg T; Müller R; Zeuzem S
    Dtsch Med Wochenschr; 2001 Feb; 126(5):97-102. PubMed ID: 11225393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B in children.
    Broderick AL; Jonas MM
    Semin Liver Dis; 2003 Feb; 23(1):59-68. PubMed ID: 12616451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection?
    Terrault NA
    Hepatology; 2000 Sep; 32(3):675-7. PubMed ID: 10991635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.